You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Drugs in MeSH Category Phosphodiesterase 5 Inhibitors


✉ Email this page to a colleague

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 202506-003 Nov 25, 2020 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Zydus Pharms TADALAFIL tadalafil TABLET;ORAL 212515-001 Jun 6, 2023 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Apotex Corp SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 091379-001 Nov 6, 2012 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Perrigo R And D SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 205791-002 Apr 23, 2020 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.